Update in Medical Treatment of Cutaneous Malignancies

1. Correlate clinical presentations of cutaneous T-cell lymphoma (CTCL) with T cell subtypes.
2. Describe an appropriate treatment plan that is appropriate for Stage of disease.
3. Use and interpret diagnostic tests for diagnosing and subtyping CTCL’s.
4. Review changes in incidence and overall survival for melanoma with new systemic therapies of the last decade.
5. Describe 2 major classes of systemic therapy for melanoma and mechanisms of action for each class.
6. Discuss cutaneous toxicities as related to new systemic therapies in melanoma.
7. Introduce upcoming developments in the systemic treatment of melanoma.

These activities are directed to physicians and advanced practice clinicians in dermatology, immunology, oncology, rheumatology, internal medicine, and other health care professionals caring for patients with autoimmune, chronic inflammatory, and advanced malignant diseases.

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Activity Director

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Faculty

Kevin Cooper, MD
Professor, Dermatology and Pathology
Case Western Reserve University School of Medicine
Interim Division Chief, Dermatology
University Hospitals Rainbow Babies and Children’s Hospital
Chairman, Department of Dermatology
University Hospitals Cleveland Medical Center
Cleveland, OH

Pauline Funchain, MD
Department of Hematology and Medical Oncology
Cleveland Clinic Cancer Center
Cleveland Clinic
Cleveland, OH

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.